Kathleen A. Gilmartin - 08 Aug 2022 Form 4 Insider Report for U S PHYSICAL THERAPY INC /NV (USPH)

Role: Director
Signature: /s/ Kathleen A Gilmartin
Issuer symbol: USPH
Transactions as of: 08 Aug 2022
Net transactions value: +$55,356
Form type: 4
Filing time: 09 Aug 2022, 11:55:44 UTC
Previous filing: 18 May 2022
Next filing: 26 Aug 2022
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	USPH	Common Stock	Purchase	$55,356	+600	+5.3%	$92.26	11,880	08 Aug 2022	Direct	F1, F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The price reported is a weighted average price $92.26. The shares were purchased in multiple transactions at prices ranging from $92.25 to $92.32 per share, both inclusive. The reporting person undertakes to provide to U.S. Physical Therapy, Inc., any of its shareholders or the staff of the Securities & Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote to this Form 4.
F2	Includes 1,200 shares of common stock which were granted as restricted stock pursuant to the Company Amended and Restated 2003 Stock Incentive Plan. Restrictions lapse as to 400 shares lapsed on each of October 1, 2022, January 1, 2023, and April 1, 2023, if she is a director of the Company on those dates.

Content

The price reported is a weighted average price $92.26. The shares were purchased in multiple transactions at prices ranging from $92.25 to $92.32 per share, both inclusive. The reporting person undertakes to provide to U.S. Physical Therapy, Inc., any of its shareholders or the staff of the Securities & Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote to this Form 4.

Includes 1,200 shares of common stock which were granted as restricted stock pursuant to the Company Amended and Restated 2003 Stock Incentive Plan. Restrictions lapse as to 400 shares lapsed on each of October 1, 2022, January 1, 2023, and April 1, 2023, if she is a director of the Company on those dates.